Concepedia

Publication | Open Access

Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis

DOIFull Paper Access

103

Citations

10

References

2015

Year

Cris S. Constantinescu, Aliya Asher, Waldemar Fryze, Wojciech Kozubski, Frank Wagner, Jehan Aram, Radu Tănăsescu, Roman Korolkiewicz, Maren Dirnberger‐Hertweck, Stefan Steidl,
Neurology Neuroimmunology & Neuroinflammation

Abstract

This phase 1b study provides Class I evidence that MOR103 has acceptable tolerability in patients with MS.

References

YearCitations

Page 1